B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphoma.

Despite advances in the understanding of diffuse large B-cell lymphoma (DLBCL) biology, only the clinically based International Prognostic Index (IPI) is used routinely for risk stratification at diagnosis. To find novel prognostic markers, we analyzed flow cytometric data from 229 diagnostic DLBCL samples using an automated multiparameter data analysis approach developed in our laboratory. By using the developed automated data analysis pipeline, we identified 71 of 229 cases as having more than 35% B cells with a high side scatter (SSC) profile, a parameter reflecting internal cellular complexity. This high SSC B-cell feature was associated with inferior overall and progression-free survival (P = .001 and P = .01, respectively) and remained a significant predictor of overall survival in multivariate Cox regression analysis (IPI, P = .001; high SSC, P = .004; rituximab, P = .53). This study suggests that high SSC among B cells may serve as a useful biomarker to identify patients with DLBCL at high risk for relapse. This is of particular interest because this biomarker is readily available in most clinical laboratories without significant alteration to existing routine diagnostic strategies or incurring additional costs.

[1]  E. Petersdorf.  The major histocompatibility complex: a model for understanding graft-versus-host disease. , 2013, Blood.

[2]  T. Helleday,et al.  PCNA (proliferating cell nuclear antigen) , 2012 .

[3]  Hans-Georg Müller,et al.  Functional Data Analysis , 2016 .

[4]  G. Chinnadurai,et al.  RBBP8 (retinoblastoma binding protein 8) , 2011 .

[5]  Y. Zhang.  CKS1B (CDC28 protein kinase regulatory subunit 1B) , 2011 .

[6]  G. Courtois.  CYLD (cylindromatosis (turban tumor syndrome)) , 2011 .

[7]  A. Eychène,et al.  MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)) , 2011 .

[8]  Ali Bashashati,et al.  A Survey of Flow Cytometry Data Analysis Methods , 2009, Adv. Bioinformatics.

[9]  Ryan R Brinkman,et al.  Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. , 2009, Blood.

[10]  Robert Gentleman,et al.  flowCore: a Bioconductor package for high throughput flow cytometry , 2009, BMC Bioinformatics.

[11]  L. Staudt,et al.  Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.

[12]  L. de Leval,et al.  The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP , 2008, Haematologica.

[13]  Raphael Gottardo,et al.  Automated gating of flow cytometry data via robust model‐based clustering , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[14]  E. White,et al.  Programmed cell death in cancer progression and therapy , 2008 .

[15]  Victoria Del Gaizo Moore,et al.  Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push? , 2008, Advances in experimental medicine and biology.

[16]  Andrew Lister,et al.  Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[18]  R. Gascoyne,et al.  Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study. , 2006, Blood.

[19]  A. Keating,et al.  Biomarkers of potential prognostic significance in diffuse large B‐cell lymphoma , 2006, Cancer.

[20]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[21]  P. Chattopadhyay,et al.  Seventeen-colour flow cytometry: unravelling the immune system , 2004, Nature Reviews Immunology.

[22]  D. Ruppert.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2004 .

[23]  C Bruce Bagwell,et al.  DNA histogram analysis for node‐negative breast cancer , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[24]  Jonathan M Irish,et al.  Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. , 2004, Clinical immunology.

[25]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[26]  L. Staudt,et al.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. , 2004, Blood.

[27]  Jelle J. Goeman,et al.  A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..

[28]  Holden T Maecker,et al.  Performance of plate-based cytokine flow cytometry with automated data analysis , 2003, BMC Immunology.

[29]  Adrian Wiestner,et al.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Gaulard,et al.  Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). , 2003, Blood.

[32]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[33]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[34]  Mario Roederer,et al.  Dear Reader, , 2003, Nature Medicine.

[35]  M. Roederer,et al.  The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. , 2002, Clinical chemistry.

[36]  Noel R. Rose,et al.  Manual of clinical laboratory immunology , 2002 .

[37]  M Roederer,et al.  Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. , 2001, Cytometry.

[38]  M Roederer,et al.  Frequency difference gating: a multivariate method for identifying subsets that differ between samples. , 2001, Cytometry.

[39]  R Tibshirani,et al.  Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. , 2001, Blood.

[40]  Geoffrey J. McLachlan,et al.  Finite Mixture Models , 2019, Annual Review of Statistics and Its Application.

[41]  Geoffrey J. McLachlan,et al.  Robust mixture modelling using the t distribution , 2000, Stat. Comput..

[42]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[43]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[44]  Klaus Rajewsky,et al.  Somatic hypermutation in normal and transformed human B cells , 1998, Immunological reviews.

[45]  J C Reed,et al.  Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. , 1997, Blood.

[46]  J Hermans,et al.  Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  K. Offit,et al.  BCL-6 in diffuse large-cell lymphomas. , 1996, Important advances in oncology.

[48]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[49]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[50]  N. L. Johnson,et al.  Breakthroughs in Statistics , 1992 .

[51]  Overton Wr,et al.  Modified histogram subtraction technique for analysis of flow cytometry data , 1988 .

[52]  W R Overton,et al.  Modified histogram subtraction technique for analysis of flow cytometry data. , 1988, Cytometry.

[53]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .

[54]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[55]  D.,et al.  Regression Models and Life-Tables , 2022 .